Skip to main content
SpringerLink
Log in

Kardiovaskuläres Risiko bei Typ-2-Diabetes

ACCORD-Studie (Action to Control Cardiovascular Risk in Diabetes)

Kardiovascular risk in type 2 diabetes

ACCORD study (Action to Control Cardiovascular Risk in Diabetes)

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Cholesterol Treatment Trialists (CTT) Collaboration, Baigent C, Blackwell L, Emberson J (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170000 participants in 26 randomised trials. Lancet 376:1670–1681

    Article  Google Scholar 

  2. Deutsche Hochdruckliga, Deutsche Hypertonie Gesellschaft (2010) Zielblutdruckwerte bei Patienten mit Diabetes mellitus. www.paritaet.org/rr-liga/dhlstatement1.htm

  3. Jun M, Foote C, Lv J et al (2010) Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet 375:1875–1884

    Article  PubMed  CAS  Google Scholar 

  4. Matthaei S, Bierwirth R, Fritsche A et al (2010) Behandlung des Diabetes mellitus Typ 2. Praxis-Leitlinie der Deutschen Diabetes-Gesellschaft. Diabetol Stoffw 5 (Suppl 2):S127–S132

    Article  Google Scholar 

  5. Riddle MC (2010) Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the action to control cardiovascular risk in diabetes (ACCORD) trial. Circulation 122:844–846

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin:

Beratungs- und Referententätigkeit für MSD, Novartis, Roche, Takeda, Astra Zeneca, BMS, Boehringer Ingelheim, Daiichi Sankyo.

Author information

Authors and Affiliations

  1. Allgemeine Innere Medizin, Gastroenterologie, Endokrinologie, Diabetologie & Stoffwechsel, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099, Hamburg, Deutschland

    D. Müller-Wieland

  2. Werl-Westönnen, Deutschland

    S. Nitschmann

Authors
  1. D. Müller-Wieland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Müller-Wieland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller-Wieland, D., Nitschmann, S. Kardiovaskuläres Risiko bei Typ-2-Diabetes. Internist 52, 601–604 (2011). https://doi.org/10.1007/s00108-011-2843-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-011-2843-2

Search

Navigation